Evidence map›Paper›PMID 40845058›Full record

ArticlePloS one2025

Transcranial focused ultrasound to nucleus accumbens reverses fentanyl-induced conditioned place preference in rats.

Seung-Schik Yoo, Madeline S Ewell, Evan C Smith, Isabel L Yu, Hyun-Chul Kim, Rajeev I Desai

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seung-Schik YooDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Madeline S EwellBehavioral Biology Program, Integrative Neurochemistry Laboratory, McLean Hospital, Belmont, Massachusetts, United States of America.
Evan C SmithCenter for Drug Discovery, Departments of Chemistry and Chemical Biology and Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America.
Isabel L YuBehavioral Biology Program, Integrative Neurochemistry Laboratory, McLean Hospital, Belmont, Massachusetts, United States of America.
Hyun-Chul KimDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.ORCID 0000-0001-7943-3295
Rajeev I DesaiBehavioral Biology Program, Integrative Neurochemistry Laboratory, McLean Hospital, Belmont, Massachusetts, United States of America.ORCID 0000-0002-4053-5996

Funding

Training Program on Development of Medications for Substance Use DisorderT32DA055553 · NIDA · NORTHEASTERN UNIVERSITY · PI Raymond G. Booth, Alexandros Makriyannis · 2022 to 2026
$1.3M
NIDA NIH HHS T32 DA055553
6 · The paper itself

Abstract

Fentanyl-related opioid use disorder (OUD) continues to be a substantial public health concern. Current pharmacological treatments, using methadone and buprenorphine, can cause adverse side effects, and patients often relapse, necessitating alternative treatment strategies. Transcranial focused ultrasound (tFUS), a noninvasive neuromodulation technique with deep brain penetrability and high spatial selectivity, is emerging as a potential intervention for treatment of OUD. To evaluate utility of tFUS in modulating the function of reward circuitry, we applied functionally suppressive tFUS to the nucleus accumbens (nAcc) of male rats to determine if it attenuated fentanyl-induced conditioned place preference (CPP). Fentanyl CPP scores were significantly attenuated following tFUS administration to the nAcc, suggesting tFUS application weakens the rewarding effects of fentanyl in rats. Physiological, behavioral, and neuropathological endpoints were unaffected by tFUS, confirming that other factors did not contribute to the observed effects. Taken together, these results support the use of tFUS as a potential treatment strategy of OUD by non-invasively modulating activity in key reward-related brain regions implicated in OUD.

Indexed as

Conditioning, PsychologicalFentanylNucleus AccumbensOpioid-Related DisordersAnalgesics, OpioidAnimalsBehavior, AnimalMaleRatsRats, Sprague-DawleyRewardAnalgesics, OpioidFentanyl

Identifiers

PMID40845058
PMCPMC12373176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.